Related Experiment Video
Updated: Aug 11, 2026

Observational Study Protocol for Repeated Clinical Examination and Critical Care Ultrasonography Within the Simple Intensive Care Studies
Published on: January 16, 2019
The Chronic Renal Insufficiency Cohort (CRIC) Study: Design and Methods
Harold I Feldman1, Lawrence J Appel, Glenn M Chertow
1Center for Clinical Epidemiology, Philadelphia, 19104, USA. hfeldman@cceb.med.upenn.edu
The Chronic Renal Insufficiency Cohort (CRIC) study investigates chronic renal insufficiency (CRI) and cardiovascular disease (CVD) risk factors. Findings aim to identify high-risk patients for targeted therapies and preventive strategies.
Area of Science:
- Nephrology
- Cardiology
- Epidemiology
Background:
- Limited understanding of chronic renal insufficiency (CRI) epidemiology and its link to cardiovascular disease (CVD).
- Need for research on risk factors for CRI progression and CVD in affected patients.
Purpose of the Study:
- To examine risk factors for CRI progression and CVD in CRI patients.
- To develop models for identifying high-risk subgroups.
- To inform future treatment trials and preventive therapy application.
Main Methods:
- Enrollment of ~3000 diverse adults (21-74 yrs) with varying renal disease severity, including those with diabetes.
- Exclusion of patients with polycystic kidney disease or on immunosuppression for glomerulonephritis.
- Annual clinical evaluations, semi-annual telephone follow-ups, and serial measurements including (125)I-iothalamate clearances and CVD assessments (ECG, echocardiogram, CT).
Main Results:
- Data collection on quality of life, diet, physical activity, health behaviors, depression, cognitive function, and healthcare utilization.
- Serial (125)I-iothalamate clearances to assess renal function.
- Comprehensive cardiovascular disease evaluations including ECG, echocardiogram, and CT scans.
Conclusions:
- Planned analyses will identify potential risk factors for progressive CRI and CVD.
- Study insights will generate hypotheses for targeted interventional trials.
- Aims to reduce the overall burden of CRI and CVD.
Related Concept Videos
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Continuous Renal Replacement Therapy
Acute Kidney Injury I: Introduction
Acute Kidney Injury IV: Diagnostic Studies and Prevention
